Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3186 results

Sort By:

AIIM Trial: Personalized Medicine Approach to Kidney Allograft Function

Study ID: NCT05432765
Start Date: 2025-12
End Date: 2027-01-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

34

Intervention / Treatment

Phenotypic Personalized Medicine Dosing

Standard of Care Dosing

Sponsor

University of Florida

Source: clinicaltrials.gov

Share:
Add to list

Impact of Isoflurane and Sevoflurane on Oxidative Stress in Patients Undergoing Laparoscopic Cholecystectomy

Study ID: NCT07152912
Start Date: 2025-09-04
End Date: 2026-03-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Isoflurane

Sevoflurane

Sponsor

Ain Shams University

Source: clinicaltrials.gov

Share:
Add to list

Acupuncture With/Without Self-acupressure for Post-oophorectomy Hot Flashes in BRCA Carriers

Study ID: NCT05331209
Start Date: 2026-01-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Acupuncture

Acupuncture-Acupressure

Sponsor

Shaare Zedek Medical Center

Source: clinicaltrials.gov

Share:
Add to list

RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry

Study ID: NCT07136363
Start Date: 2025-11-01
End Date: 2026-11-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

DynamiCare

Patient Navigation (PN)

Sponsor

University of Texas Southwestern Medical Center

Source: clinicaltrials.gov

Share:
Add to list

NovoTTF-200A + Pembrolizumab In Melanoma Brain Metastasis

Study ID: NCT04129515
Start Date: 2025-10-30
End Date: 2027-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

NovoTTF-200A

Pembrolizumab

Sponsor

Brown University

Source: clinicaltrials.gov

Share:
Add to list

Anticariogenic Effect of Moringa Oleifera Mouthwash Compared to Chlorhexidine Mouthwash

Study ID: NCT04575948
Start Date: 2025-12
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

90

Intervention / Treatment

Moringa Oleifera

Chlorhexidine mouthwash

Base formula

Sponsor

Misr International University

Source: clinicaltrials.gov

Share:
Add to list

Genetic Analysis of Uncommon Disease Presentations in Non-US Populations

Study ID: NCT06595940
Start Date: 2025-09-08
End Date: 2034-08-21
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment
Sponsor

National Human Genome Research Institute (NHGRI)

Source: clinicaltrials.gov

Share:
Add to list

City-hospital Collaboration for the Early Screening of Hepatic Fibrosis in Primary Care: a Secondary Prevention Project in the Grenoble Health Basin

Study ID: NCT07031089
Start Date: 2025-11-02
End Date: 2028-11-02
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

Non-interventional study (RIPH category 3)

Sponsor

University Hospital, Grenoble

Source: clinicaltrials.gov

Share:
Add to list

D-FAB-POUR Trial: Dexmedetomidine vs Fentanyl as Adjuvants to Bupivacaine on Postoperative Urinary Retention

Study ID: NCT07117565
Start Date: 2025-09-15
End Date: 2026-11-25
Study Type

Interventional

Study Phase

Phase4

No. of Participants

190

Intervention / Treatment

Intervention 1: Intrathecal Dexmedetomidine with Bupivacaine

Intervention 2: Intrathecal Fentanyl with Bupivacaine

Sponsor

Tribhuvan University Teaching Hospital, Institute Of Medicine.

Source: clinicaltrials.gov

Share:
Add to list

Environment and Alcohol: A Pilot Study

Study ID: NCT06860607
Start Date: 2025-09-08
End Date: 2028-03-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

44

Intervention / Treatment

Evaluate the effects of Environmental Enrichment (EE) on alcohol consumption

Sponsor

National Institute on Drug Abuse (NIDA)

Source: clinicaltrials.gov

Share:
Add to list